May 19, 2025
1:50
For every 50 shares held, investors received 1. The price per share adjusted from $0.01 to $0.26.
The split itself did not change the total investment value.
Vaxil Bio Ltd. (OTC:VXLLF) operates in the Biotechnology industry.
Vaxil Bio Ltd. company overviewVaxil Bio Ltd.'s most recent stock split was on May 19, 2025. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
Vaxil Bio Ltd. (OTC:VXLLF) has split its stock 4 times: a 1-for-2 reverse split on October 30, 2012, a 1-for-7 reverse split on October 9, 2014, a 1-for-2 reverse split on March 10, 2016, and a 1-for-50 reverse split on May 19, 2025.
Vaxil Bio Ltd. has split its stock 4 times. This history records 4 reverse splits between October 30, 2012 and May 19, 2025.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Vaxil Bio Ltd.'s 1-for-50 reverse split on May 19, 2025, every 50 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Vaxil Bio Ltd. has not announced a new split in our records. Its most recent split was on May 19, 2025, 1 year ago. Companies announce splits in advance, and any new OTC:VXLLF split will appear on this page.
Already premium?